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Abstract Tropomyosin, a ubiquitous protein in animals
and fungi, is associated with the actin cytoskeleton and is
involved with stabilising actin filaments and regulating the
interaction of the filament with other actin binding pro-
teins. The protein is best known for its role in regulating
the interaction between actin and myosin in muscle con-
traction but in recent years its role as a major player in the
organisation and dynamics of the cytoskeleton has been
increasingly recognised. In mammals Tpm is expressed
from four distinct genes and alternate splicing of each gene
can produce a total of up to 40 different mRNA variants
most of which are expressed as proteins. We are expecting
a renaissance in the study of tropomyosins as the roles of
these different isoforms are beginning to be deciphered.
However, it is our belief that such a renaissance is being
limited by confusion over the naming systems for the
tropomyosin isoforms. These result in even experienced
workers struggling to reconcile work done in different
laboratories and at different times. We propose here a
systematic nomenclature for tropomyosin based on the best
current practice. We recommend the adoption of these
names and a cross-reference to the table of alternate names
and accession numbers for protein sequences is included
here. The National Center for Biotechnology Information
(NCBI) website has been amended to include the nomen-
clature for the human, mouse and rat genes.
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Tropomyosin (Tpm) is a protein family associated with the
stabilisation and regulation of the actin cytoskeleton
(Gunning et al. 2008). It is expressed in opisthokonts
including animals and fungi, but is not documented in
plants, protists or procaryotes (Barua et al. 2011; Cranz-
Mileva et al. 2013). Tpm polymerises head to tail as a two-
chained coiled coil along both sides of a helical actin fil-
ament stabilising the actin structure and interacting with a
range of other actin binding proteins to regulate the actin
cytoskeleton. The protein was discovered in the 1940s as a
component of the actin filaments of striated muscle (Bailey
1946) and this remains the best studied example of Tpm
function. In striated muscle, together with troponin, it
enables calcium regulation of striated muscle contraction
by blocking (-Ca2?) or allowing (?Ca2?) myosin access
to its binding site on actin (Gordon et al. 2000; Geeves
2012). Since the 1940s the different possible roles of Tpm
and the number of interacting partners has multiplied (see
special issue of J Muscle Res. Cell Motil., Marston &
Gautel 2013). We now know that in mammalian cells Tpm
is expressed from four separate genes and alternate pro-
moter selection and splicing of each gene can produce up to
40 different mRNA variants most of which have been
shown to be expressed as proteins in different tissues
(Pittenger et al. 1994; Vindin and Gunning 2013).
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The steady discovery of different splice variants in
specific tissues has, over the years, led to a proliferation
of different names for the isoforms, some identified with
specific tissues but later found with a broader distribu-
tion. This has resulted in a great deal of confusion in the
literature and it is often difficult, even for those of us in
the field, to be sure which isoforms we are each referring
to. It must be an even bigger nightmare for those trying
to enter the field. The lack of a coherent nomenclature is
an impediment to progress. We firmly believe that Tpm
research is due for a renaissance from both the structure–
function perspective in muscle research and the cyto-
plasmic perspective in the localisation-function of dis-
tinct isoforms and their binding partners. This is
evidenced by the collection of articles published in a
special issue of J Muscle Res Cell Motil devoted to Tpm
Marston & Gautel (2013). This renaissance will be
enhanced if we can establish a widely agreed-upon
nomenclature that the majority of active researchers will
use. It will be much better if we can establish this now
as the field begins to expand and other pressures develop
on the nomenclature.
After consulting colleagues working with Tpm we now
make a specific proposal for how the nomenclature could
be simplified and rationalised and to make it compatible
with current best practice for gene and protein names. The
proposal keeps as close as possible to some well-estab-
lished historical precedents.
Our suggestion is that any publication dealing with the
tropomyosin protein should designate, at the first use, the
formal name of the protein isoform as proposed here, and
then define the short form or abbreviation that will be
used thereafter in the article text. Reference to Tables 1,
2, 3 and 4 here will allow cross-reference to any earlier
versions of the names used e.g., a-fast skeletal tropomy-
osin is Tpm1.1.
Detailed proposals
1. The human tropomyosin genes should be known as
TPM1 through TPM4 (Tpm1 through Tpm4 for mouse
and rat tropomyosin) to be consistent with other gene
nomenclatures.
2. The protein short nameTm is historicallywell established
but Tpm is consistentwith standard protein nomenclature
and is therefore preferred in the formal name.
3. Tpm1 or Tpm2 specifies the protein is from gene
TPM1 or TPM2 etc.
4. Alternate isoforms are numbered systematically from
one (e.g., Tpm1.1 etc.), keeping as close as possible to
any precedent. Thus Tpm2.3 is the tropomyosin
isoform from gene 2 isoform 3.
5. In the formal name a subscript designates the tissue
most closely associated, historically, with the protein
isoform. Many such isoforms have been since found in
multiple tissues and such designations are not always
useful.
• St striated muscle, cardiac/skeletal tissue
• Sm smooth muscle,
• Br brain
• Cy other cytoplasmic
6. The splicing of the four exons that vary in vertebrates
can be designated by a four letter code; a.a.b.d
indicates exon 1 is splice form a, exon 2 is splice
form a, exon 6 is splice form b and exon 9 is splice
form d.
• A dash as in b.-.b.d indicates that exon 2 is missing
and therefore this is a short form of Tpm.
• Previous publications of Tpm isoforms have indi-
cated that exon 9 can be a combination of two
splice forms at the mRNA level (e.g., Vindin and
Gunning 2013) but these reflect splice variants in
non-coding regions at the 30 end of the mRNA
transcripts. We have therefore omitted such iso-
forms from our list of expressed proteins.
7. The formal names of the two tropomyosins from the
TPM1 gene, found in the contractile filaments of
smooth muscle, are then
Tpm1.3Sm(a.a.b.d) and Tpm1.4Sm(a.a.a.d)
The short form of the name would be Tpm1.3 and Tpm1.4
Tables 1, 2, 3 and 4 list the current, known Tpm protein
isoforms and the proposed formal names. As far as possible
the alternate names for the same protein that have been
used in the past are included in columns two and three. We
also include, in Table 5, the full set of human Tpm amino
acid sequences in the order that the exons appear in the
gene. This will allow any ambiguity in the literature to be
checked against the names and exon sequences used here.
A fuller list of animal Tpm sequences can be found in
Barua et al. 2011 and Schevzov et al. 2011.
It is almost certain that additional isoforms of tropo-
myosin will be identified in these species. Consideration of
all possible splicing combinations already established in at
least one isoform leads to a calculation of 48 possible
distinct isoforms in humans without consideration of cur-
rently unknown splicing alternatives. For example, Cooley
and Bergtrom (2001) identified an increased number of
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Table 1 List of tropomyosin isoforms derived from the human TPM1 gene (geneID:7168), the mouse Tpm1 gene(geneID:22003) or the rat
Tpm1 gene (geneID:24851). Gene structure
1a 2a 2b 1b 3      4      5     6a 6b 7    8   9a 9b 9c 9d





Alternate names in use Formal protein
name
Accession numbers
Full length sequences onlya
Exon usageb
Tpm1.1 Tm ska aTm, fast skTm ,
cardiac Tm, striated Tm
Tpm1.1st (a.b.b.a) Human: NP_001018005.1
Mouse: NP_001157720.1
Rat: NP_001288265.1




Tpm1.3 Tm sma-1 a smooth Tm Tpm1.3sm (a.a.a.d) Human: NP_001018020.1
Mouse: none
Rat: NP_001029243.1
Tpm1.4 Tm sma Tm6, a smooth Tm
Tm a1.2
Tpm1.4sm (a.a.b.d) Human: NP_001018007.1
Mouse: NP_001157721.1
Rat: AAA21804.1
Tpm1.5 Tm3-1 - Tpm1.5cy (a.b.a.a) Human: NP_000357.3
Mouse: NP_001157723.1
Rat: none
Tpm1.6 Tm2 - Tpm1.6cy (a.b.b.d) Human: NP_001018004.1
Mouse: NP_077745.2
Rat: NP_001029241.1
Tpm1.7 Tm3 Tm 1.4 Tpm1.7cy (a.b.a.d) Human: NP_001018006.1
Mouse: NP_001157722.1
Rat: NP_001029242.1
Tpm1.8 Tm5a - Tpm1.8cy (b.-.b.d) Human: NP_001288218.1
Mouse: NP_001157724.1
Rat: NP_001029245.1
Tpm1.9 Tm5b - Tpm1.9cy (b.-.a.d) Human: none
Mouse: NP_001157725.1
Rat: NP_001029246.1
Tpm1.10 TmBr1 - Tpm1.10br (a.b.b.c) Human: none
Mouse: NP_001157727.1
Rat: NP_001029244.1
Tpm1.11 TmBr2 - Tpm1.11br (b.-.b.b) Human: none
Mouse: none
Rat: NP_062004.1
Tpm1.12 TmBr3 Tmbra, Tmbra-1 Tm a-1.6 Tpm1.12br (b.-.b.c) Human: NP_001018008.1
Mouse: NP_001157728.1
Rat: NP_001288665.1
Tpm1.13 - - Tpm1.13 (b.-b.a) Human: none
Mouse: NP_001157726.1
Rat: NP_001029247.1
a The accession numbers are from September, 2014 and for full-length human, mouse and rat protein sequences that have been documented at
the nucleic acid level. RefSeq numbers are listed when available. The N-terminal Met is removed post translation in all exon 1b-encoded
sequences. As far as is currently known the N-terminal amino acid is N-acetylated post translation in all isoforms. NCBI website has been
updated to include the above terminology
b The exon notation includes only the protein-coding exons and does not reflect splice variants in non-coding regions at the 30 end of the mRNA
transcripts
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potential isoforms from the TPM1 gene using RT-PCR.
Our ability to detect and confirm additional isoforms will
depend on both the extent of expression across, and the
levels of expression in, different cell types.
The NCBI accession numbers for each isoform are
included in Tables 1, 2, 3 and 4 and the human, mouse and
rat genes on the NCBI website have been amended to use
the nomenclature as listed here.
Table 2 List of tropomyosin isoforms derived from the human TPM3 gene (geneID:7170), the mouse Tpm3 gene (geneID:59069) or the rat











Full length sequences onlya
Exon usageb
Tpm3.12 Tm ska-slow cTm asTm1,
slow skTm
Tpm3.12st (a.b.b.a) Human: NP_689476.2
Mouse: NP_001280677.2 Rat:
NP_001288214.1
Tpm3.13 - - Tpm3.13cy (a.b.a.d) Human: none
Mouse: NP_071709.2
Rat: none
Tpm3.1 Tm5NM1 - Tpm3.1cy(b.-.a.d) Human: NP_705935.1
Mouse: NP_001240667.1
Rat: NP_775134.1
Tpm3.2 Tm5NM2 - Tpm3.2cy(b.-.b.d) Human: NP_001036816.1
Mouse: NP_001240669.1
Rat: none
Tpm3.3 Tm5NM3 - Tpm3.3cy(b.-.b.a) Human: EAW53237.1
Mouse: none
Rat: NP_001288215.1
Tpm3.4 Tm5NM4 - Tpm3.4cy (b.-.b.c) Human: NP_001036818.1
Mouse: NP_001280678.1
Rat: NP_476556.2
Tpm3.5 Tm5NM5 - Tpm3.5cy(b.-.a.a) Human: NP_001265118.1
Mouse: NP_001258693.1
Rat: none
Tpm3.7 Tm5NM7 - Tpm3.7cy (b.-.a.c) Human: NP_001036817.1
Mouse: none
Rat: none
Tpm3.8 Tm5NM8 - Tpm3.8cy (b.-.a.a/c)c Human: none
Mouse: none
Rat: none
Tpm3.9 Tm5NM9 - Tpm3.9cy (b.-.b.a/c)c Human: none
Mouse: none
Rat: none
a The accession numbers are from September, 2014 and for full-length human, mouse and rat protein sequences that have been documented at
the nucleic acid level. RefSeq numbers are listed when available. The N-terminal Met is removed post translation in all exon 1b-encoded
sequences. As far as is currently known the N-terminal amino acid is N-acetylated post translation in all isoforms. NCBI website has been
updated to include the above terminology
b The exon notation includes only the protein-coding exons and does not reflect splice variants in non-coding regions at the 30 end of the mRNA
transcripts
c The designation a/c indicates that the ninth exon includes exon 9a and five amino acids from exon 9c
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Table 4 List of tropomyosin isoforms derived from the human TPM4 gene (geneID:7171), the mouse Tpm4 gene (geneID:326618) or the rat
gene Tpm4 (geneID:248512)a. Gene structure
Short name Common names Alternate names
in use
Formal protein name Accession numbers
Full length sequences onlyb
Exon usagec
Tpm4.1 Tm4HMW dTm Tpm4.1cy (a.b.b.d) Human: NP_001138632.1
Mouse: none
Rat: none
Tpm4.2 Tm4 - Tpm4.2cy (b.-.b.d) Human: NP_003281.1
Mouse: NP_001001491.1
Rat: NP_036810.1
a The TPM4 gene of humans (but not rat or mouse) contains exon 9a but there are no reported Tpm4 isoforms expressing exon 9a. Exon 9a is
present in other vertebrates e.g., chicken, frog and zebrafish
b The accession numbers are from September, 2014 and for full-length human, mouse and rat protein sequences that have been documented at
the nucleic acid level. RefSeq numbers are listed when available. The N-terminal Met is removed post translation in all exon 1b-encoded
sequences. As far as is currently known the N-terminal amino acid is N-acetylated post translation in all isoforms. NCBI website has been
updated to include the above terminology
c The exon notation includes only the protein-coding exons and does not reflect splice variants in non-coding regions at the 30 end of the mRNA
transcripts
Table 3 List of tropomyosin isoforms derived from the human TPM2 gene (geneID:7169), the mouse Tpm2 gene (geneID:22004) or the rat





Alternate names in use Formal protein name Accession numbers
Full length sequences onlyb
Exon usagec
Tpm2.1 Tm smb bTm Tm1, Tm1b,smooth Tm,
smooth a-Tm
Tpm2.1sm/cy (a.b.a.d) Human: NP_998839.1
Mouse: NP_001264805.1
Rat: NP_001019516.1
Tpm2.2 Tm skb b skeletal Tm, b cardiac Tm Tpm2.2st (a.b.b.a) Human: NP_003280.2
Mouse: NP_033442.2
Rat: NP_001288164.1








a The TPM2 genes in mouse, rat and human do not contain exon 1b. It is included here as it is found in chicken and zebrafish
b The accession numbers are from September, 2014 and for full-length human, mouse and rat protein sequences that have been documented at
the nucleic acid level. RefSeq numbers are listed when available. The N-terminal Met is removed post translation in all exon 1b-encoded
sequences. As far as is currently known the N-terminal amino acid is N-acetylated post translation in all isoforms. NCBI website has been
updated to include the above terminology
c The exon notation includes only the protein-coding exons and does not reflect splice variants in non-coding regions at the 30 end of the mRNA
transcripts
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Table 5 Human tropomyosin amino acid sequences in order of the exons in the gene
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